Cargando…

C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation

Chemoresistance is a major unmet clinical obstacle in ovarian cancer treatment. Epigenetics plays a pivotal role in regulating the malignant phenotype, and has the potential in developing therapeutically valuable targets that improve the dismal outcome of this disease. Here we show that a series of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Dan, Zhang, Xiao-Xue, Li, Meng-Chen, Cao, Can-Hui, Wan, Dong-Yi, Xi, Bi-Xin, Tan, Jia-Hong, Wang, Ji, Yang, Zong-Yuan, Feng, Xin-Xia, Ye, Fei, Chen, Gang, Wu, Peng, Xi, Ling, Wang, Hui, Zhou, Jian-Feng, Feng, Zuo-Hua, Ma, Ding, Gao, Qing-Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928165/ https://www.ncbi.nlm.nih.gov/pubmed/29712898 http://dx.doi.org/10.1038/s41467-018-03590-5

Ejemplares similares

AF10 (MLLT10) prevents somatic cell reprogramming through regulation of DOT1L-mediated H3K79 methylation
por: Uğurlu-Çimen, Deniz, et al.
Publicado: (2021)

Platinum–copper single atom alloy catalysts with high performance towards glycerol hydrogenolysis
por: Zhang, Xi, et al.
Publicado: (2019)

Metabolic reprogramming of three major nutrients in platinum-resistant ovarian cancer
por: Yan, Jinbowen, et al.
Publicado: (2023)

Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism
por: Leung, Dilys, et al.
Publicado: (2022)

How does C/EBPα speed up cell reprogramming?
por: Sardina, Jose Luis, et al.
Publicado: (2016)

Epigenetic drug library screening reveals targeting DOT1L abrogates NAD(+) synthesis by reprogramming H3K79 methylation in uveal melanoma
por: Gu, Xiang, et al.
Publicado: (2023)

Surgery in platinum-resistant recurrent epithelial ovarian carcinoma
por: Zhao, Ling-Qin, et al.
Publicado: (2022)

DOT1L and H3K79 Methylation in Transcription and Genomic Stability
por: Wood, Katherine, et al.
Publicado: (2018)

Methylation of H3 K4 and K79 is not strictly dependent on H2B K123 ubiquitylation
por: Foster, Elinor R., et al.
Publicado: (2009)

CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
por: Jiang, You, et al.
Publicado: (2021)

Decitabine reactivated pathways in platinum resistant ovarian cancer
por: Fang, Fang, et al.
Publicado: (2014)

Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer
por: Yang, Ling, et al.
Publicado: (2022)

Aberrant DNA methylation reprogramming in bovine SCNT preimplantation embryos
por: Zhang, Sheng, et al.
Publicado: (2016)

Metabolic reprogramming of the ovarian cancer microenvironment in the development of antiangiogenic resistance: Metabolic reprogramming of the OC microenvironment
por: Yue, Huiran, et al.
Publicado: (2023)

The AML-associated K313 mutation enhances C/EBPα activity by leading to C/EBPα overexpression
por: Gentle, Ian Edward, et al.
Publicado: (2021)

Altered DNA Methylation Patterns of the H19 Differentially Methylated Region and the DAZL Gene Promoter Are Associated with Defective Human Sperm
por: Li, Bo, et al.
Publicado: (2013)

CYP79 P450 monooxygenases in gymnosperms: CYP79A118 is associated with the formation of taxiphyllin in Taxus baccata
por: Luck, Katrin, et al.
Publicado: (2017)

Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells
por: Tan, Yuying, et al.
Publicado: (2022)

Real-time assessment of platinum sensitivity of primary culture from a patient with ovarian cancer with extensive metastasis and the platinum sensitivity enhancing effect by metformin
por: Liu, Yingzhao, et al.
Publicado: (2018)

Inhibition of histone H3K79 methylation selectively inhibits proliferation, self-renewal and metastatic potential of breast cancer
por: Zhang, Li, et al.
Publicado: (2014)

Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
por: Ball, Graeme, et al.
Publicado: (2017)

CPT2 K79 acetylation regulates platelet life span
por: Fan, Xuemei, et al.
Publicado: (2022)

ACOX1, regulated by C/EBPα and miR-25-3p, promotes bovine preadipocyte adipogenesis
por: Zhang, Feng, et al.
Publicado: (2021)

Epigenetic control of influenza virus: role of H3K79 methylation in interferon-induced antiviral response
por: Marcos-Villar, Laura, et al.
Publicado: (2018)

Correction to: CYP79 P450 monooxygenases in gymnosperms: CYP79A118 is associated with the formation of taxiphyllin in Taxus baccata
por: Luck, Katrin, et al.
Publicado: (2017)

Functional genetic variants of CTNNBIP1 predict platinum treatment response of Chinese epithelial ovarian cancer patients
por: Li, Haoran, et al.
Publicado: (2020)

Inflammation-activated C/EBPβ mediates high-fat diet-induced depression-like behaviors in mice
por: Li, Yiyi, et al.
Publicado: (2022)

The risk model construction of the genes regulated by H3K36me3 and H3K79me2 in breast cancer
por: Wang, Ling-Yu, et al.
Publicado: (2023)

Platinum-Resistant Ovarian Cancer Is Vulnerable to the cJUN-XRCC4 Pathway Inhibition
por: Xu, Manman, et al.
Publicado: (2022)

Systematic analysis of ovarian cancer platinum-resistance mechanisms via text mining
por: Li, Haixia, et al.
Publicado: (2020)

Low-dose-intensity bevacizumab with weekly irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer
por: Liu, Ying, et al.
Publicado: (2015)

Platinum-Based Neoadjuvant Chemotherapy for Breast Cancer With BRCA Mutations: A Meta-Analysis
por: Wang, Chang-Jun, et al.
Publicado: (2020)

Macrophages Phenotype Regulated by IL-6 Are Associated with the Prognosis of Platinum-Resistant Serous Ovarian Cancer: Integrated Analysis of Clinical Trial and Omics
por: Wu, Xiaoqing, et al.
Publicado: (2023)

Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients
por: Liu, Rong, et al.
Publicado: (2017)

Seven Genes Based Novel Signature Predicts Clinical Outcome and Platinum Sensitivity of High Grade IIIc Serous Ovarian Carcinoma
por: Liu, Gang, et al.
Publicado: (2018)

DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation
por: Godfrey, Laura, et al.
Publicado: (2019)

Differential Methylation of H3K79 Reveals DOT1L Target Genes and Function in the Cerebellum In Vivo
por: Bovio, Patrick Piero, et al.
Publicado: (2018)

Overexpression of SMYD3 in Ovarian Cancer is Associated with Ovarian Cancer Proliferation and Apoptosis via Methylating H3K4 and H4K20
por: Jiang, Yahui, et al.
Publicado: (2019)

Tripartite motif containing 26 prevents steatohepatitis progression by suppressing C/EBPδ signalling activation
por: Xu, Minxuan, et al.
Publicado: (2023)

Palmitate induces fat accumulation by activating C/EBPβ-mediated G0S2 expression in HepG2 cells
por: Zhao, Nai-Qian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4fg6okadbl46bj6bd27f9ef576